FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073814 [Registered on: 12/09/2024] Trial Registered Prospectively
Last Modified On: 10/09/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Dentistry 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Use of Clove oil,Lemongrass,Ginger oil and Hyaluronic acid gel in addition to teeth cleaning to cure severe gum diseases 
Scientific Title of Study   Comparative evaluation of clinical efficacy of clove oil,lemongrass, ginger oil and hyaluronic acid gel as local drug delivery in the treatment of stage-I and stage II Periodontitis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Boyapati Ramanarayana 
Designation  Professor 
Affiliation  SIBAR INSTITUTE OF DENTAL SCIENCES 
Address  Department of Periodontology, Second floor, Room number-8, Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh, PIN CODE-522509 India

Guntur
ANDHRA PRADESH
522509
India 
Phone  9490144365  
Fax    
Email  dr.ramanarayana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Boyapati Ramanarayana 
Designation  Professor 
Affiliation  SIBAR INSTITUTE OF DENTAL SCIENCES 
Address  Department of Periodontology, Second floor, Room number-8, Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh, PIN CODE-522509 India

Guntur
ANDHRA PRADESH
522509
India 
Phone  9490144365  
Fax    
Email  dr.ramanarayana@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Boyapati Ramanarayana 
Designation  Professor 
Affiliation  SIBAR INSTITUTE OF DENTAL SCIENCES 
Address  Department of Periodontology, Second floor, Room number-8, Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh, PIN CODE-522509 India

Guntur
ANDHRA PRADESH
522509
India 
Phone  9490144365  
Fax    
Email  dr.ramanarayana@gmail.com  
 
Source of Monetary or Material Support  
Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh, India, PINCODE-522509 
 
Primary Sponsor  
Name  Dr Boyapati Ramanarayana 
Address  Department of Periodontology, Second floor, Room number-8, Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh,India, PIN CODE-522509  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Boyapati Ramanarayana  Sibar Institute of Dental Sciences  Department of Periodontology,Second floor, Room number-8, Sibar Institute of Dental Sciences, Takkellapadu, Guntur, Andhra Pradesh, India, PIN CODE-522509
Guntur
ANDHRA PRADESH 
9490144365

dr.ramanarayana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Sibar Institute of Dental Sciences, Guntur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Lemongrass oral in-situ gel  Lemongrass oil, rich in phenols and flavonoids, exhibits antioxidant, anti-inflammatory, and antimicrobial effects, inhibiting various microorganisms at under 2% concentration 
Intervention  Clove oil oral in-situ gel   Clove oil, rich in eugenol, has antibacterial, antifungal, and anti-inflammatory properties, benefiting dental care, wound healing, and overall health.  
Intervention  Ginger oil oral in-situ gel  Ginger, containing beta-bisabolol, gingerol, and paradol, offers anti-inflammatory, antioxidant, and anti-cancer benefits, aiding in glycemic control and periodontal health 
Intervention  Hyaluronic acid oral in-situ gel  Hyaluronic acid, a glycosaminoglycan, aids healing and tissue regeneration, reducing inflammation and matrix metalloproteinases, enhancing chemotherapeutic and periodontal treatments. 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  44.00 Year(s)
Gender  Both 
Details  1.Patients with Stage I and Stage II Periodontitis.
2.Patients within the age group of 35 to 44 years of age for both genders.
3.Subjects with no history of allergies to the components used in the study
4.Apparently healthy individuals
 
 
ExclusionCriteria 
Details  1.Patients with habits like any form of tobacco, or alcohol consumption.
2.Systemically compromised patients
3.Pregnant women or lactating mothers
4.Patients who are on medication that influences periodontal health.
5.Patients with impacted teeth, non-functional teeth or prosthetic restorations
6.Patients who will not be able to be attend for follow up visits
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Centralized 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Improvement in clinical attachment level
2.Reduction of Periodontal Pocket Probing
Depth 
baseline,1 month and 3 months
 
 
Secondary Outcome  
Outcome  TimePoints 
better wound healing (PISA index)  baseline,1 month and 3 months
 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The primary goal of periodontal therapy is removal of the biofilm deposits and create an environment conducive for the shift of microbiome from pathobionts to symbionts. This is often achieved by the gold standard- scaling and root planning (SRP) procedure, alone or with adjunctive administration of systemic or local antimicrobial agents, and surgical periodontal therapy, if required. However, use of systemic antimicrobials were shown to have adverse effects such as drug toxicity, acquired bacterial resistance, poor patient compliance and unwanted drug interactions. To tackle these limitations, local delivery of antibacterial agents into periodontal pocket is being extensively used. 
The benefits of using local drug delivery include better patient compliance, enhanced pharmacokinetic response, greater access and ability to position the drug adjacent to the disease and ability to lower total dosage of the drug at a more controlled concentration. Similarly, phytotherapy has long been a source of medicinal products and over the years there have been many attempts to use herbal medicines for the treatment of chronic periodontitis, with the advantage of few side effects and cost-effectiveness.Natural products are the drugs of choice due to novelty in their chemical structure and mechanism of action. 
Clove oil, rich in eugenol, has antibacterial, antifungal, and anti-inflammatory properties, benefiting dental care, wound healing, and overall health.Ginger, containing beta-bisabolol, gingerol, and paradol, offers anti-inflammatory, antioxidant, and anti-cancer benefits, aiding in glycemic control and periodontal health.Lemongrass oil, rich in phenols and flavonoids, exhibits antioxidant, anti-inflammatory, and antimicrobial effects, inhibiting various microorganisms at under 2% concentration.Hyaluronic acid, a glycosaminoglycan, aids healing and tissue regeneration, reducing inflammation and matrix metalloproteinases, enhancing chemotherapeutic and periodontal treatments.Taking the above facts into account, the present study is planned to compare the clinical efficacy of clove oil, ginger oil, lemongrass, and hyaluronic acid gel as an adjunct to scaling and root planning in the management of stage-1 and stage-2 periodontitis.


 
Close